Mycophenolate mofetil Completed Phase 2 Trials for Multiple Myeloma and Plasma Cell Neoplasm / Chronic Myeloproliferative Disorders / Myelodysplastic Syndromes / Graft Versus Host Disease (GVHD) / Myelodysplastic/Myeloproliferative Diseases / Malignant Lymphomas / Leukemias Supportive Care

IndicationsStatusPurposePhase
CompletedSupportive Care2
clinicaltrials.gov IdentifierTitleDrugs
NCT00096096Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation